US$ 23.51
glp 1 hypoglycemia Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in GLP-1 and the kidney: from
Description
In a phase II trial, participants with obesity were randomly assigned to various doses of retatrutide from 14 , 8, or 12 mg or a placebo for 48 weeks [19]

However, unlike small molecule drugs conjugated with antibodies, in the case of MariTide, peptides are conjugated

Frequently Asked Questions Which GLP-1 has the least side effects

Primary Handling Editor: Ming Yang, in collaboration with the Nature Medicine team